We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
-1.57%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.1B
AUM Growth
-$130M
Cap. Flow
-$69.8M
Cap. Flow %
-6.34%
Top 10 Hldgs %
64.92%
Holding
92
New
13
Increased
10
Reduced
17
Closed
20

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$18M
2
COUR icon
Coursera
COUR
+$1.72M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$45M
2
MU icon
Micron Technology
MU
+$16.7M
3
CLF icon
Cleveland-Cliffs
CLF
+$12.5M
4
AAPL icon
Apple
AAPL
+$9.57M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.66M

Sector Composition

Rank Sector Weight
1 Financials 12.62%
2 Energy 5.05%
3 Technology 5.03%
4 Materials 4.82%
5 Consumer Staples 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLF icon
51
CALL
Cleveland-Cliffs
CLF
$6.89B
$2.69M 0.24%
+200,000
New +$3.33M
BMRN icon
52
BioMarin Pharmaceuticals
BMRN
$11.7B
$2.62M 0.24%
30,953
– –
CHWY icon
53
PUT
Chewy
CHWY
$9.01B
$2.4M 0.22%
+78,000
New +$3.09M
MPT
54
PUT
Medical Properties Trust
MPT
$2.91B
$2.37M 0.22%
200,000
+100,000
+100% +$1.51M
CAT icon
55
PUT
Caterpillar
CAT
$400B
$2.21M 0.2%
13,500
-16,500
-55% -$3.01M
TWTR
56
PUT
DELISTED
Twitter, Inc.
TWTR
$2.1M 0.19%
+48,000
New +$1.95M
ASA
57
ASA Gold and Precious Metals
ASA
$963M
$1.53M 0.14%
122,351
– –
NTLA icon
58
Intellia Therapeutics
NTLA
$1.52B
$1.49M 0.14%
26,646
– –
MCHP icon
59
PUT
Microchip Technology
MCHP
$42.6B
$1.4M 0.13%
23,000
-77,000
-77% -$5.06M
FSR
60
PUT
DELISTED
Fisker Inc.
FSR
$1.24M 0.11%
164,500
-35,500
-18% -$320K
CRSP icon
61
CRISPR Therapeutics
CRSP
$4.65B
$1.23M 0.11%
18,876
– –
TSLA icon
62
PUT
Tesla
TSLA
$1.22T
$1.06M 0.1%
4,000
-86,000
-96% -$24M
WVE icon
63
Wave Life Sciences
WVE
$1.15B
$696K 0.06%
192,722
– –
RARE icon
64
Ultragenyx Pharmaceutical
RARE
$2.67B
$658K 0.06%
15,885
– –
CHWY icon
65
CALL
Chewy
CHWY
$9.01B
$614K 0.06%
+20,000
New +$794K
SGMO
66
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$395K 0.04%
80,650
– –
EDIT icon
67
Editas Medicine
EDIT
$416M
$352K 0.03%
28,797
– –
SLN
68
Silence Therapeutics
SLN
$572M
$251K 0.02%
25,000
– –
AFMD
69
DELISTED
Affimed
AFMD
$206K 0.02%
10,000
– –
ADAP
70
DELISTED
Adaptimmune Therapeutics
ADAP
$124K 0.01%
115,602
– –
CLLS
71
Cellectis
CLLS
$286M
$117K 0.01%
50,907
– –
BLUE
72
DELISTED
bluebird bio
BLUE
$71K 0.01%
561
– –
AAPL icon
73
CALL
Apple
AAPL
$4.93T
– –
-70,000
Closed -$9.57M
AAPL icon
74
Apple
AAPL
$4.93T
– –
-70,000
Closed -$9.57M
AAPL icon
75
PUT
Apple
AAPL
$4.93T
– –
-100,000
Closed -$13.7M
1 2
3
4

Similar funds

OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.13B AUM
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

WS Management's Q3 2022 Portfolio in Review

As of Q3 2022, WS Management held 92 positions worth $1.1B, down 11% from $1.23B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

WS Management withdrew a net $69.8M in Q3 2022, closing 20 positions and reducing 17 holdings. Its most notable exit was Cleveland-Cliffs, an estimated $12.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Energy and Technology.

Against the trend, WS Management added an estimated $18M to ConocoPhillips.

  • WS Management added most to ConocoPhillips in Q3 2022, an estimated $18M increase.
  • WS Management's biggest Q3 2022 reduction was SPDR Gold Trust, cutting an estimated $45M.
  • WS Management fully exited Cleveland-Cliffs in Q3 2022, selling an estimated $12.5M.
  • WS Management's ten largest holdings make up 65% of its $1.1B portfolio in Q3 2022.
  • WS Management opened 13 new positions and closed 20 in Q3 2022.
  • WS Management's portfolio value fell 11% quarter-over-quarter to $1.1B.

Based on WS Management's 13F filing for Q3 2022, filed 14 Nov 2022.